Fluticasone-Salmeterol Drug Combination [kombinace léků salmeterol a fluticason]
- Terms
-
Airflusan
Airflusan Forspiro
Brecur
Everio
fluticason a salmeterol
fluticason-propionát a salmeterol-xinafoát
flutikason-propionát a salmeterol-xinafoát
Fullhale
kombinace léků fluticason a salmeterol
kombinace léků flutikason a salmeterol
kombinace léků flutikason-propionát a salmeterol-xinafoát
Salticon
Seretide
-
Advair
Advair Diskus
Advair HFA
Fluticasone - Salmeterol
Fluticasone Propionate - Salmeterol
Fluticasone Propionate - Salmeterol Combination
Fluticasone Propionate - Salmeterol Xinafoate
Fluticasone Propionate-Salmeterol Drug Combination
Fluticasone Propionate-Salmeterol Xinafoate Combination
Fluticasone Propionate-Salmeterol Xinafoate Drug Combination
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone-Salmeterol Combination
Seretide
A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
- DUI
- D000068297 MeSH Browser
- CUI
- M000623538
- History note
- 2016 (2001)
- Public note
- 2016; FLUTICASONE PROPRIONATE-SALMETEROL XINAFOATE DRUG COMBINATION was indexed under ALBUTEROL 2001-2015; and under ANDROSTADIENES 2001-2015.
Allowable subheadings
- AD
- administration & dosage 6
- AE
- adverse effects 2
- AG
- agonists
- AA
- analogs & derivatives
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 6
- TO
- toxicity
- UR
- urine